ERIN DUHON: Open Payments
NPI 1235595828 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 43 payments from 15 companies in 2025. Trend: 2023 $370 · 2024 $442 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $209 |
| REVANCE THERAPEUTICS, INC. | 1 | $104 |
| Madrigal Pharmaceuticals | 4 | $78 |
| Ardelyx, Inc. | 2 | $51 |
| Celltrion USA Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $24 |
| GENZYME CORPORATION | 1 | $21 |
Products named: SKYRIZI, DAXXIFY, REZDIFFRA, IBSRELA, RINVOQ, VEGZELMA, Wegovy, IQIRVO.
Industry payments across LA — which companies pay providers there.
